Risk Factors for Refractory Immune Checkpoint Inhibitor-related Pneumonitis in Patients With Lung Cancer: Erratum : Journal of Immunotherapy

Secondary Logo

Journal Logo

Erratum

Risk Factors for Refractory Immune Checkpoint Inhibitor-related Pneumonitis in Patients With Lung Cancer: Erratum

Journal of Immunotherapy 46(3):p 120, April 2023. | DOI: 10.1097/CJI.0000000000000462
  • Free

In the study that published in the February/March 2023 issue, a fund number was incorrect in the Financial Disclosures section. The number of GDPH Supporting Fund for NSFC Program should be 8210032051 not 8190120260. This has been corrected in the online version of the manuscript.

REFERENCE

1. Tan P, Huang W, He X, et al. Risk factors for refractory immune checkpoint inhibitor-related pneumonitis in patients with lung cancer. J Immunother. 2023;46:64–73. doi:10.1097/CJI.0000000000000451
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.